Yes, but according to the study:I disagree with your disagreement. This is a surrogate-type data collection methodology that requires the parents (the surrogate reporter) to report on the child's (study subject) symptomology, which by nature is qualitative. This type of study, often done in such "soft" pediatric studies, is rife with reporting bias, especially when unblinded.
"After stratification for age (ages 2-5, 6-11, and 12-18 years), each child was randomly assigned in a partially double-blinded fashion to receive artificially honey-flavored DM . . . buckwheat honey, or nothing in a 10-mL syringe. A compounding pharmacy prepared the DM to approximate the consistency, texture, flavor, smell, and sweetness of honey. The randomization sequence was constructed by a statistician not affiliated with the study . . . and was then used by the study coordinators to assign treatment groups.
"The syringes used for all of the 3 treatment groups were opaque and were placed in brown paper bags to avoid investigator unblinding. Although the no-treatment group was not blinded to their treatment arm, the honey and DM groups remained blinded."
It wasn't intended to be complete. The title is "Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents"Secondly, the endpoint is, as mentioned, qualitative and doesn't really address any true effect on the disease process or associated symptoms. This study is far from robust, and no real meaningful conclusions can be drawn from it. Given the fact that honey has inherent risks in and of itself (C. botulinum, child with previously undiagnosed fructosuria or other related metabolic disorders, etc.), not addressed in this study, renders it also far from complete.
Yes, but "[t]he objective of this trial was to compare the effects of a single nocturnal dose of honey or honey-flavored DM with no treatment on nocturnal cough and the sleep difficulty associated with URIs." The trial seemed to establish that honey was superior to no treatment. So, I think it was an important first step. Follow-up studies are now needed.In other words, you can't make any meaningful clinical conclusions about (1) the lack of effectiveness of DM, or (2) the safety of honey, and therefore the study's clinical impact is essentially nil.
